XML 82 R71.htm IDEA: XBRL DOCUMENT v3.21.2
Share-Based Compensation (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
May 05, 2021
Apr. 02, 2021
Feb. 12, 2021
Dec. 02, 2019
Jun. 29, 2021
Jun. 25, 2021
May 27, 2021
Jan. 26, 2021
Jun. 30, 2021
Jun. 30, 2021
Share-Based Compensation (Details) [Line Items]                    
Common stock authorized awards to granted (in Shares)                 3,333,334 3,333,334
Number of shares (in Shares)         655,002 8,333,334 1,820,000      
Number of shares issued (in Shares)                   5,430,505
Number of shares forfeited (in Shares)                   33,334
Exercised shares (in Shares)                   63,333
Number of common shares authorized (in Shares)                   2,936,163
Aggregate of restricted stock (in Shares)       633,336            
Fair value of per share $ 0.873     $ 2.46     $ 0.505      
Restricted stock units, description                   The original vesting period for these RSAs is as follows: 283,339 were to vest on the one-year anniversary of the grant date; 283,331 were to vest on the two-year anniversary of the original grant date; and 66,666 were scheduled to vest on the three-year anniversary of the original grant date. As of December 31, 2020, 283,339 RSAs had vested. In the first quarter of fiscal 2021, the Company modified the RSA awards for two individuals to accelerate the final vesting of their awards in consideration of the individuals’ separation and/or retirement. This modification resulted in the vesting of an additional 50,000 RSAs. An incremental compensation expense was recognized for the modification totaling $0.17 million during the six months ended June 30, 2021. As of June 30, 2021, the remaining unvested RSAs from these awards, totaling 299,997, are scheduled to vest as follows: 233,331 are scheduled to vest on the two-year anniversary of the original grant date; and 66,666 were scheduled to vest on the three-year anniversary of the original grant date.
Fair value of per share               $ 4.50    
Vesting period, description               The vesting period for these RSAs is as follows: 33,334 vest on the one-year anniversary of the grant date and 33,333 vest on the two-year anniversary of the original grant date.    
Vested percentage                 100.00% 100.00%
Recognized of compensation expense (in Dollars)         $ 130       $ 180 $ 530
Unrecognized compensation cost (in Dollars)                   640
Aggregate of purchase shares (in Shares)   2,458,163                
Exercise price $ 2.75 $ 2.75         $ 4.50      
Aggregate of shares common stock (in Shares) 295,000 1,778,837                
Service period description Of these, 270,000 have a one-year service period and vest ratably on the six month and twelve-month anniversary of their authorization for issuance and 25,000 vested immediately upon grant. Of these, 753,837 have a three-year service period and vest ratably on the first, second and third anniversary of their authorization for issuance and 1,025,000 have a two-year service period and vest ratably on the first and second anniversary of their authorization for issuance.                
Recognized of share-based compensation expense (in Dollars)                 $ 340 350
Unrecognized compensation expense (in Dollars)                   $ 3,950
Exercise per share price     $ 5.3125              
Estimated per share     $ 1.918              
Aggregate of purchase shares (in Shares)     225,882              
Weighted average grant date fair value per share                   $ 1.390
Minimum [Member]                    
Share-Based Compensation (Details) [Line Items]                    
Fair value of per share   $ 0.961       $ 0.759        
Exercise price   2.75                
Maximum [Member]                    
Share-Based Compensation (Details) [Line Items]                    
Fair value of per share   1.042       $ 0.768        
Exercise price   $ 3.025                
Warrant [Member]                    
Share-Based Compensation (Details) [Line Items]                    
Exercise price               $ 4.15    
Aggregate of shares common stock (in Shares)               2,751,556    
Exercise per share price               $ 4.50    
Estimated per share               $ 1.597    
Warrant to purchase (in Shares)               100,000    
Expiration date               Jan. 21, 2026    
Warrants price per share               $ 1.703    
Warrant One [Member]                    
Share-Based Compensation (Details) [Line Items]                    
Exercise price               $ 5.1875    
Warrant to purchase (in Shares)               154,216    
Warrants price per share               $ 1.376    
Warrants Two [Member]                    
Share-Based Compensation (Details) [Line Items]                    
Exercise price               $ 4.50    
Warrant to purchase (in Shares)               4,433,734    
Warrants price per share               $ 1.597    
Board of Directors [Member]                    
Share-Based Compensation (Details) [Line Items]                    
Aggregate of restricted stock (in Shares)               66,667